Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hip Replacements
FDA Approval Allows Stryker to Market Hip Resurfacing System In Third Quarter of 2007
July 22nd, 2007
Stryker Corporation (NYSE:SYK) announced that it will begin marketing Corin Group PLC's Cormet Hip Resurfacing System as early as the third quarter of this year. This follows today's FDA approval of Cormet and is predicated on a comprehensive surgeon education protocol developed by Stryker and Corin, in cooperation with the FDA, emphasizing patient selection criteria to promote successful outcomes. Stryker's Orthopaedics division previously secured an exclusive 10-year agreement to market and distribute the Cormet Hip Resurfacing System in the United States. Interest in hip resurfacing procedures is on the rise globally due to the bone conserving nature of the procedure...
Source: Medical Devices & Surgical Technology Week (2007-07-22)
|
